Accueil
|
International
Belgique
Česká republika
Deutschland
España
France
Italia
Nederland
Österreich
Portugal
Slovensko
Switzerland
United Kingdom
USA
Stallergenes Group
Email alert
Contact
|
About Stallergenes
Stallergenes share
Shareholder area
Results
Publications
News
Publications
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2009
Annual reports
See
Reference document
Download
Corporate repport
Download
Half-yearly report
See
Half-year report
Download
Press releases
See
Very positive 3-year results of the long-term study
Download
Stallergenes is granted a marketing authorization for Oralair in Europe
Download
Stallergenes' growth strategy recognized at the "BFM Awards"
Download
Continued dynamic growth: cumulative sales to the end of september 2009 up ...
Download
Immunotherapy tablet containing recombinant allergen of birch pollen: posit...
Download
A brand name for the 2nd sublingual desensitization tablet produced by Stal...
Download
First half-year 2009: performance ahead of expectations
Download
Strong sales growth in 1st half-year: up 12%, Full-year guidance maintained
Download
House dust mites desensitization tablets: Positive results from a phase IIb...
Download
1st quarter 2009: favourable developments
Download
2008: a strong performance
Download
Exclusive partnership with Solvay Pharmaceuticals in Russia and the CIS
Download
Oralair® Grasses obtains a pediatric Market Authorisation in Germany
Download
2008: Sales up 16%
Download
Liquidity contracts
See
June 30th
Download
December 31th
Download
Statements of voting rights
See
January 31th
Coming soon
February 27th
Download
March 31th
Download
April 30th
Download
May 29th
Download
June 30th
Download
July 31th
Download
August 31th
Download
September 30th
Download
October 30th
Download
November 30th
Download
December 31th
Download